SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
グルコース代謝を調節する抗糖尿病薬で、SDR16C6に関連する経路に影響を及ぼす可能性がある。 | ||||||
Insulin抗体() | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
グルコースと脂質代謝の重要な調節因子として、インスリンは間接的にSDR16C6の活性に影響を与える可能性がある。 | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPARγアゴニストで、脂質とグルコースの代謝に影響を与え、SDR16C6に影響を与える可能性がある。 | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
もう一つのPPARγアゴニストは脂質とグルコースの代謝を変化させ、SDR16C6に影響を与える可能性がある。 | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
α-グルコシダーゼ阻害剤で、糖質代謝に影響を与え、SDR16C6に影響を与える可能性がある。 | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
PPARαアゴニストとして、フェノフィブラートは脂質代謝を調節し、SDR16C6に影響を与える可能性がある。 | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
脂質代謝に影響を与え、SDR16C6関連経路に影響を与える可能性がある。 | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
スタチンはコレステロール代謝に影響を与え、SDR16C6に影響を与える可能性がある。 | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
リパーゼを阻害し、脂質の消化吸収に影響を与え、SDR16C6に影響を与える可能性がある。 | ||||||